https://www.selleckchem.com/pr....oducts/way-262611.ht
PERSPECTIVE In this study, fiber-specific DLss test showed potential in identifying sensory changes that are specific for painful neuropathy, encouraging future testing of this approach as a biomarker for early detection of painful CIPN. TRIAL REGISTRATION The study was approved by the Washington University Institutional Review Board (#201807162) and registered at ClinicalTrials.gov (NCT0368797. Functional gastrointestinal disorders are common and costly to the healthcare system. In the Multidisciplinary Treatment of Functional Gas
Like
Comment
Share
